|
RLYB Rallybio Corp 1739410 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$43,665,000.00 |
| Balance Sheet |
|
Current Assets
|
$97,253,000.00 |
|
Assets
|
$98,063,000.00 |
|
Current Liabilities
|
$3,567,000.00 |
|
Liabilities
|
$3,567,000.00 |
|
Equity
|
$94,496,000.00 |
|
Shares Out
|
5306894.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$37,941,000.00 |
|
Investing Cash Flow
|
$23,400,000.00 |
| Market Analysis |
Market Cap
|
$88,094,440.40 |
|
Price
|
$17.19 |
|
BVPS
|
17.81 |
|
PB
|
0.93 |
|
EPS
|
7.66 |
|
PS
|
98.69 |
|
FCF
|
$37,941,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:51 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:41 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RLYB documents filed with the SEC.
RLYB Filings
Clear
